Form 4: Establishment Labs Director Acquires Shares in Lieu of Cash Retainer

Director Leslie Gillin acquired 413 common shares of Establishment Labs Holdings Inc. at $40.81 per share in lieu of a quarterly cash retainer payment.

Summary

• On March 31, 2025, Leslie Gillin, a director of Establishment Labs Holdings Inc., acquired 413 common shares.
• The shares were received in lieu of a quarterly cash retainer payment.
• The price per share was $40.81.
• Following the transaction, Gillin beneficially owns 11,297 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction related to director compensation. The director taking shares instead of cash is a slightly positive sign.

Positives

• A director's decision to take shares in lieu of cash may signal confidence in the company's future prospects.

Industry Context

Directors receiving shares as compensation is a common practice, aligning their interests with those of shareholders. This is a standard method of compensation for board members.

Comparison to Industry Standards

• Director compensation packages vary across the industry, but equity-based compensation is a common component.
• Comparing Establishment Labs' director compensation policy with those of similar-sized medical device companies would provide a benchmark.
• Companies like Sientra or Allergan (now AbbVie) could be considered for comparison, focusing on the proportion of equity versus cash in director compensation.

Related Party Transactions

• The acquisition of shares in lieu of a cash retainer payment is a related party transaction, as it involves a director and the company.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It reinforces the alignment of director interests with shareholder value.

Key Dates

Keywords

Establishment Labs, ESTA, Director, Share Acquisition, Form 4, Insider Trading, Equity Incentive Plan, Common Shares